Earth Science Tech ETST
OTC ETST
$0.09 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Earth Science Tech (ETST) Income towards Parent Company (2011 - 2026)

Earth Science Tech's (ETST) quarterly Income towards Parent Company came in at $715697.0 in Q2 2026, up 56.71% on a YoY basis from $456714.0 in Q2 2025, and down 44.43% quarter-over-quarter from $1.3 million in Q1 2026.

Analysis

Earth Science Tech (ETST) Income towards Parent Company (2011 - 2026) Analysis & Trends

Earth Science Tech (ETST) has reported Income towards Parent Company for 15 consecutive years, with $715697.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income towards Parent Company rose 56.71% year-over-year to $715697.0; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (up 46.54% YoY), and the FY2026 full-year result was $3.6 million, up 10.67% from the prior year.
  • Income towards Parent Company fell to $715697.0 in Q2 2026 per ETST's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $1.3 million in Q1 2026 and bottomed at -$235509.0 in Q1 2023.
  • Historically, Income towards Parent Company has averaged $446551.9 across 5 years, with a median of $336952.5 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Income towards Parent Company sank 667.61% in 2023, then surged 3123.53% in 2024.
  • Over 5 years, Income towards Parent Company stood at $98464.0 in 2022, then jumped by 128.96% to $225443.0 in 2023, then slipped by 8.44% to $206411.0 in 2024, then jumped by 341.05% to $910368.0 in 2025, then retreated by 21.38% to $715697.0 in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $715697.0, $1.3 million, and $910368.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn
10 Earth Science Tech 25.88 Mn 23.09 Mn 6.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 715,697.00
Mar 31, 2026 1.29 Mn
Dec 31, 2025 910,368.00
Sep 30, 2025 945,897.00
Jun 30, 2025 456,714.00
Mar 31, 2025 1.17 Mn
Dec 31, 2024 206,411.00
Sep 30, 2024 798,368.00
Jun 30, 2024 1.08 Mn
Mar 31, 2024 229,324.00
Dec 31, 2023 225,443.00
Sep 30, 2023 444,581.00
Jun 30, 2023 -35,596.00
Mar 31, 2023 -235,509.00
Dec 31, 2022 98,464.00
Sep 30, 2022 -73,678.00
Jun 30, 2022 -154,682.00
Mar 31, 2022 -30,681.00
Dec 31, 2021 -115,048.00
Sep 30, 2021 3.34 Mn